Joan Goverman

Joan Goverman

Auto-generated profile, based on publicly available information

Joan Goverman

Department of Immunology, University of Washington, Seattle, WA, USA

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2009 in Nature Reviews Immunology
Verified
Journal Article
Open access
PDF file
JGJoan Goverman
Joan Goverman
Multiple sclerosis is thought to be mediated by autoimmune T cell responses directed against antigens derived from the central nervous system (CNS). The clinical course, symptoms and pathology seen in patients with multiple sclerosis is heterogeneous, suggesting that multiple sclerosis in different patients may result from distinct pathogenic pathways. Autoimmune disease in the CNS occurs when self-reactive T cells specific for CNS antigens are activated in the periphery, either by presentation of the self antigen in the CNS-draining (cervical) lymph nodes or by a molecular mimic of the self antigen. Unlike naive T cells, activated T cells can cross the blood–cerebrospinal fluid (CSF) or blood–brain barrier. Activated T cells are believed to initially cross the blood–CSF barrier and enter the subarachnoid space, where their reactivation facilitates activation of the vascular endothelium and subsequent T cell entry into the perivascular space. The myelin-specific CD4+ T cells that mediate CNS autoimmunity in animal models are usually T cells that circulate in the periphery because they escaped central tolerance owing to low avidity for their cognate antigen. Both CD4+ T helper 1 (TH1) cells, characterized by interferon-γ (IFNγ) secretion, and TH17 cells, characterized by interleukin-17 (IL-17) secretion, can induce CNS autoimmune disease. The interplay between these T cell subsets as well as their interaction with other cells that reside within the CNS is poorly understood but is likely to have an important role in shaping the inflammatory response in different locations within the CNS. During inflammation there are many cell types that can present antigen to CD4+ T cells; the relative contribution and activation state of these different antigen-presenting cells strongly influences the effector function and survival of T cells in the CNS. CD8+ T cells exhibit more evidence of antigen-driven expansion in the CNS of patients with multiple sclerosis, and myelin-specific CD8+ T cells are highly pathogenic in experimental autoimmune encephalomyelitis. However, in addition to CD4+ regulatory T cells, several different types of regulatory CD8+ T cells have been described that may be important in the pathology of multiple sclerosis. Despite the fact that T cells are believed to be the primary effector cells in the pathology of multiple sclerosis, depletion of B cells is a promising therapeutic treatment for patients with multiple sclerosis. It is not yet clear whether the beneficial effect of this therapy is due to disruption of the antigen-presenting function of B cells or their ability to produce antibodies.

5 December 2016 in Nature Reviews Immunology
Verified
Journal Article
Closed access
BBBurkhard Becher
Burkhard Becher
SSSabine Spath
Sabine Spath
JGJoan Goverman
Joan Goverman

1 February 1993 in Cell
Verified
Journal Article
Closed access
JGJoan Goverman
Joan Goverman
AWAndrea Woods
Andrea Woods
LLLisa Larson
Lisa Larson
LWLeslie P. Weiner
Leslie P. Weiner
LHLeroy Hood
Leroy Hood
DZDennis M. Zaller
Dennis M. Zaller

17 February 2008 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
ISIngunn M Stromnes
Ingunn M Stromnes
LCLauren M Cerretti
Lauren M Cerretti
DLDenny Liggitt
Denny Liggitt
RHRobert A Harris
Robert A Harris
JGJoan M Goverman
Joan M Goverman

16 November 2006 in Nature Protocols
Verified
Journal Article
Closed access
ISIngunn M Stromnes
Ingunn M Stromnes
JGJoan M Goverman
Joan M Goverman

3 September 2001 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
EHEric S. Huseby
Eric S. Huseby
DLDenny Liggitt
Denny Liggitt
TBThea Brabb
Thea Brabb
BSBryan Schnabel
Bryan Schnabel
CÖClaes Öhlén
Claes Öhlén
JGJoan Goverman
Joan Goverman
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system (CNS) characterized by plaques of infiltrating CD4+ and CD8+ T cells. Studies of MS and experimental autoimmune encephalomyelitis (EAE), an animal model of MS, focus on the contribution of CD4+ myelin-specific T cells. The role of CD8+ myelin-specific T cells in mediating EAE or MS has not been described previously. Here, we demonstrate that myelin-specific CD8+ T cells induce severe CNS autoimmunity in mice. The pathology and clinical symptoms in CD8+ T cell–mediated CNS autoimmunity demonstrate similarities to MS not seen in myelin-specific CD4+ T cell–mediated EAE. These data suggest that myelin-specific CD8+ T cells could function as effector cells in the pathogenesis of MS.